BioRexis Pharmaceutical Corporation

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercialization due to pharmacological issues. For example, many peptides that are currently approved or in development have a very short half-life, requiring both high and frequent dosing. Unwanted side effects from high peak levels can limit therapeutic benefit, and frequent trough low levels may narrow application of the particular product. High dosing per patient also places a further burden on already limited manufacturing capacity, driving up the cost of treatment, as in the case of monoclonal antibodies and other high-priced biopharmaceuticals.

Contact Details: 3400 Horizon Drive King of Prussia Pennsylvania 19406 United States of America Tel: (610) 313-4000 Fax: (610) 313-4039 Email: info@biorexis.com. WWW: www.biorexis.com/

Loading...

Recent Publications by BioRexis Pharmaceutical Corporation:
Radiotherapy of human xenograft NSCLC tumors in nude mice with a 90Y-labeled anti-tissue factor antibody. Tissue factor (TF) is a type I transmembrane protein and the initiator of...	20th September, 2005	BioRexis Pharmaceutical Corporation, King of Prussia, PA 19406, USA.	Cancer Biother Radiopharm. 2005 Jun;20(3):300-9. DOI Direct Link

Press Releases on BioRexis Pharmaceutical Corporation:
Kensey Nash Announces Appointment of Chief Financial Officer	5th March, 2009	Kensey Nash Corporation	EXTON, Pa., March 5 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative solutions and technologies for a wide range of

BioNews Results for BioRexis Pharmaceutical Corporation:
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments	Entrepreneur.com:  Nov 16 2009 4:20AM Matching: pharmaceutical
Pharmaceuticals : EmailWire.Com SEO Press Release Distribution Services and PharmaNewsWire.Com Present Free Ph	TMC Net:  Nov 14 2009 6:23PM Matching: pharmaceutical
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments	Montana's News Station:  Nov 14 2009 5:59PM Matching: pharmaceutical
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments	KSLA:  Nov 14 2009 4:28PM Matching: pharmaceutical
Teva Pharmaceutical Industries Limited - Financial And Strategic Analysis Review - New Report Published	OfficialSpin:  Nov 14 2009 10:17AM Matching: pharmaceutical
Promote your company here: BioNewsCast - Press Release Distribution	→View more BioRexis Pharmaceutical Corporation news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 605 times since April 2007, the link to the organisation's website has been followed 145 times

Recent Search Terms used to find this page: BioRexis Pharmaceutical Corporation | biorexis pharmaceuticals | biorexis antibody | BioRexis Pharmaceutical Corporation | biorexis | BIOREXIS PHARMACEUTICAL COMPANY KING OF PRUSSIA PA | Biorexis Pharmaceutical | Biorexis Pharmaceutical Corporation | Biorexis Pharmaceutical Corporation | biorexis pharmaceuticals corp pa | .

Search for more companies in King of Prussia

Search for more companies in Pennsylvania

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for BioRexis Pharmaceutical Corporation